Sections
Search
More
Podcasts
email
Created with Sketch.
Newsletters
Metro
Obituaries
Death Notices
Globe Local
Newton
Sports
Red Sox
Patriots
Celtics
Bruins
High Schools
TV & Radio
Business
Technology
Opinion
Editorials
Letters
Ideas
Politics
Rhode Island
Nation
World
Lifestyle
Food & Dining
Comics
Crossword
Travel
Names
Real Estate
Marijuana
Arts
Books
Movies
Music
Television
Visual Arts
Theater/Dance
Cars
Real Estate
Events
Search site
ePaper
Magazine
Obituaries
Weather
Comics
Crossword
Events
Manage my Account
Gladiator
Last Seen
Love Letters
STAT: The Readout Loud
All Podcasts
All Newsletters
Metro
Sports
Business
Opinion
Rhode Island
Politics
Education
Lifestyle
Marijuana
Arts
Magazine
Cars
Real Estate
Events
Stock price of German COVID-19 vaccine maker with US headquarters in Boston closes up nearly 250% in its debut
'This is kind of beyond expectations,' says CureVac's chief financial officer.
Another potential COVID-19 vaccine with Boston ties to enter clinical trials
CureVac, a German firm with about 20 employees here, says it has permission to start testing in people.
For some biotech employees in the age of COVID-19, the workday starts at the bathroom sink
Tango Therapeutics in Cambridge tests workers' gargled samples, then e-mails the results later that day.
Support Real Journalism
Subscribe to the Globe for just 99 cents
Subscribe Now
Latest Headlines in Biotech
Load more
/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/5RKCRLLEILP2MD36P4MUKSRBRA.jpg)